Search the Newsreel

DocGo Stock (DCGO) Opinions on Recent Price Movement

Social media discussions indicate that DocGo stock (DCGO) has recently declined to around $0.65 due to broader selling and short-term holders exiting positions, reflecting cautious market sentiment. DocGo reported Q1 2026 revenues of $75.6M, a 21.33% decrease year-over-year, and saw varied hedge fund activity …

Carlyle Group (CG) Could Be 12% Undervalued Following Its Q2 2026 Earnings Beat

Carlyle Group (CG) recently reported Q2 2026 earnings that surpassed analyst expectations, with record fee-related earnings and assets under management. Despite a year-to-date share price decline, the stock has seen a recent uplift, driven by strong institutional allocations to alternative investments and a growing …

Bank of America Securities Reaffirms Their Buy Rating on CG Oncology, Inc. (CGON)

Bank of America Securities reiterated a Buy rating on CG Oncology, Inc. (CGON) with an $88.00 price target. This affirmation follows the company's Q2 earnings report, which showed $1.16 million in revenue and a net profit of $0, a significant improvement from the prior …

ETFs Investing in McGrath RentCorp Stocks

This article provides a list of Exchange Traded Funds (ETFs) that hold McGrath RentCorp stocks. The ETFs are sorted by market value and include details such as issuer, management style, focus, expense ratio, assets under management (AUM), price, and 3-year total return. The information …

DCGO | DocGo Inc. Common Stock Financials - Income Statement

DOCGO Q2 2026 Earnings Preview: Recent $DCGO Insider Trading, Hedge Fund Activity, and More

CGI (GIB) Q3 2026 Earnings Call Transcript

CGI (GIB) reported its Q3 2026 earnings, showcasing revenue growth of 2.5% year-over-year, driven primarily by acquisitions, and a diluted EPS of $2.23, up 22.5%. The company emphasized its strong bookings, particularly in Managed Services, and a rising pipeline of opportunities, with a significant …

Centerra Gold (TSX:CG) Is Up 22.9% After Raising 2026 Gold Guidance And Boosting Shareholder Returns – Has The Bull Case Changed?

First Trust Advisors LP Reduces Stock Position in Carlyle Group Inc. $CG

First Trust Advisors LP significantly reduced its stake in Carlyle Group Inc. (NASDAQ:CG) by 75.8% in the first quarter of 2026, selling 165,064 shares and retaining 52,780 shares valued at approximately $2.55 million. Despite this reduction, Carlyle Group exceeded Q2 earnings and revenue expectations, …

The Carlyle Group Inc. Just Beat Revenue Estimates By 22%

The Carlyle Group Inc. (NASDAQ:CG) saw its shares rise 3.8% after reporting strong Q2 results, with revenue beating expectations by 22% and EPS matching estimates. Analysts have significantly upgraded their revenue and earnings per share forecasts for 2026, predicting substantial growth for the company, …

Enterprise value to EBITDA forward of CG Oncology, Inc. – NASDAQ:CGON

This page from TradingView provides financial information for CG Oncology, Inc. (NASDAQ: CGON), specifically focusing on its enterprise value to EBITDA forward. It indicates that the market was closed at the time of viewing and presents various navigation options related to markets, products, and …

Royal Bank of Canada Sells 240,679 Shares of Centerra Gold Inc. $CGAU

Commerzbank (XTRA:CBK) Stock Looks Strong On Returns Yet Pricey On Earnings

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Commerzbank stock has delivered a very large 5 year return, yet the current valuation checks lean expensive rather than cheap, which raises questions about …

CG Oncology (NASDAQ:CGON) Posts Earnings Results, Misses Expectations By $0.24 EPS

CG Oncology (NASDAQ:CGON) reported a wider-than-expected quarterly loss of $0.90 per share, missing consensus estimates by $0.24, despite revenue of $1.16 million surpassing expectations. The stock saw a slight increase to $75.10, near its 52-week high, and maintains a "Moderate Buy" consensus rating with …

McGrath RentCorp (MGRC) Q2 2026 Earnings Call Transcript

Carlyle Group (NASDAQ: CG) details $10,000,861,951 in institutional equity holdings

Carlyle Group Inc. (NASDAQ: CG) has filed a 13F combination report detailing $10,000,861,951 in aggregate institutional equity holdings across 19 reportable positions. The filing identifies three other included managers: Abingworth LLP, Carlyle Investment Management LLC, and CIM Global, L.L.C. It also clarifies the relationship …

Carlyle Group Inc Revenue Breakdown – LSX:A2PXCR

Carlyle Group Inc (LSX:A2PXCR) generated 3.32 billion EUR in revenue last year. The Global Private Equity segment was the top performer, contributing 1.83 billion EUR. Geographically, the Americas region was the largest contributor, accounting for 2.79 billion EUR.

Insider Ambaw Bellete plans CGON (CGON) stock sale after large prior trades

Ambaw Bellete, an insider at CG Oncology, Inc. (CGON), has filed a Form 144 indicating an intent to sell up to 9,250 shares of common stock on August 7, 2026, through Morgan Stanley Smith Barney LLC. This filing also details several significant common stock …

Royal Bank Of Canada Has Lowered Expectations for CG Oncology (NASDAQ:CGON) Stock Price

Commercial Bancgroup Ord Shs (CBK) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Commercial Bancgroup Ord Shs (CBK), indicating a "Buy" analyst rating based on one analyst's assessment. The target price is USD 34.00, with a current stock price of USD 35.060. The article also includes peer comparison data and …

Centerra Gold (TSE:CG) Reaches New 12-Month High - Here's What Happened

Carlyle Group Inc. (NASDAQ:CG) Receives Consensus Recommendation of "Hold" from Brokerages

Carlyle Group Inc. (NASDAQ:CG) has received a consensus "Hold" rating from sixteen brokerages, with an average 12-month price target of $59.79. Despite beating quarterly earnings and revenue estimates, the company experienced a 28.6% year-over-year revenue decline. Noteworthy events include raising $17 billion, a strategic …

Truist Financial Issues Positive Forecast for CG Oncology (NASDAQ:CGON) Stock Price

DocGo Inc. (NASDAQ:DCGO) Receives Consensus Rating of "Hold" from Analysts

DocGo Inc. (NASDAQ:DCGO) has received a consensus "Hold" rating from six analysts, with an average 12-month price target of $2.375, significantly higher than its recent share price of $0.62. The company exceeded revenue expectations for its latest quarter, reporting $75.55 million against an estimated …

BofA Adjusts Price Target on CG Oncology to $88 From $87

BofA Securities has raised its price target for CG Oncology (CGON) shares to $88 from $87, while maintaining a Buy rating. This adjustment follows a previous price target revision by RBC, which lowered its target to $79 from $81. The article highlights recent news …

McGraw Hill (MH) Institutional Ownership 2026 $MH

This article details the institutional ownership of McGraw Hill (NYSE:MH) stock, including buying and selling trends over the last two years. It lists major institutional shareholders, their holdings, market value, and quarterly changes. Key investors like T. Rowe Price Investment Management Inc., American Century …

How Investors Are Reacting To CG Oncology (CGON) Wider Quarterly Loss Amid Promising Phase 3 Bladder Cancer Data

CG Oncology recently reported a wider net loss of US$79.06 million in Q2 2026, while generating US$1.16 million in revenue. Despite the financial setback, the company is advancing its lead drug, cretostimogene grenadenorepvec, for non-muscle invasive bladder cancer, with promising Phase 3 data published …

CG Oncology, Inc. Stock 12‑Month Price Target Raised to $91.15, Implies 26% Upside

CG Oncology, Inc.'s average 12-month stock price target has increased from $90.69 to $91.15, based on estimates from 13 analysts, suggesting a 26% potential upside from its August 5 closing price. The consensus rating for CGON remains a "Buy" among 15 analysts, with 14 …

Prime Capital Financial Announces Strategic Partnership With Carlyle to Accelerate Next Phase of Growth

Partnership supports one of the nation's leading independent wealth management firms as it continues building a market-leading proposition for both clients and advisors. OVERLAND PARK, Kan., August 06, 2026--(BUSINESS WIRE)--Prime Capital Financial today announced that the Global Credit platform of global investment firm Carlyle …

Insider (NASDAQ: CGON) files to sell 75,000 shares after recent stock sales

Ambaw Bellete, an insider at CG Oncology, Inc. (NASDAQ: CGON), has filed to sell 75,000 shares of common stock through Morgan Stanley's Executive Financial Services program, linked to a stock option exercise on August 6, 2026. This proposed sale has an aggregate market value …

CG Oncology earnings up next amid bladder cancer therapy push By Investing.com

CG Oncology Inc. is set to report second-quarter earnings, with analysts expecting a narrower loss as the company progresses towards a regulatory filing for its bladder cancer treatment. The biotech aims to complete its Biologics License Application by Q4 2026, positioning it for potential …

Carlyle Secured Lending, Inc. Announces Financial Results For Second Quarter Ended June 30, 2026, Declares Third Quarter 2026 Dividend of $0.35 Per Common Share

Carlyle Secured Lending, Inc. NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, "we," "us," "our," "CGBD" or the "Company") (NASDAQ: CGBD) today announced its financial results for its second quarter ended June 30, 2026. Alex …

Carlyle Q2 Earnings Beat Estimates on Higher AUM, Expenses Rise Y/Y

The Carlyle Group Inc. CG reported second-quarter 2026 post-tax distributable earnings per share of $1.07, surpassing the Zacks Consensus Estimate of 88 cents. The metric also rose from 91 cents in the year-ago quarter. Results benefited from higher realized performance revenues and fee-related performance …

CG Oncology, Inc. (CGON) Reports Q2 Loss, Misses Revenue Estimates

CG Oncology, Inc. (CGON) reported a Q2 loss of $0.9 per share, missing the Zacks Consensus Estimate of a $0.7 loss, and posted revenues of $1.16 million, which fell short of estimates by 59.02%. Despite the earnings miss, the company's shares have risen 74.4% …

Why Did Centerra Gold Inc. (TSX:CG) Stock Surge 7.17% on 5 August 2026?

Earnings Flash (CGON) CG Oncology, Inc. Reports Q2 Revenue $1.2M